Blockchain Registration Transaction Record

Calidi Biotherapeutics to Showcase RedTail(TM) Platform in Investor Webinar

Calidi Biotherapeutics announces investor webinar to showcase its RedTail(TM) platform, a breakthrough in treating metastatic tumors, on July 24, 2025.

This news is significant as it highlights Calidi Biotherapeutics' progress in developing innovative cancer treatments that could offer new hope to patients with metastatic tumors. The RedTail(TM) platform's ability to evade immune detection and target tumors systemically represents a potential paradigm shift in oncology therapy. For investors and the medical community, Calidi's advancements underscore the growing importance of genetic medicine in treating complex diseases, marking a critical step forward in the quest for more effective and safer cancer treatments.